XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2021 $ 141,369 $ 16 $ 198,278 $ (57,052) $ 127
Beginning Balance, shares at Dec. 31, 2021   16,168,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (6,476)     (6,476)  
Other comprehensive income (loss), net of tax (429)       (429)
Issuance of restricted stock, shares   30,000      
Stock options exercised 361   361    
Stock options exercised, shares   47,000      
Stock-based compensation 1,537   1,537    
Ending Balance at Mar. 31, 2022 136,362 $ 16 200,176 (63,528) (302)
Ending Balance, shares at Mar. 31, 2022   16,245,000      
Beginning Balance at Dec. 31, 2021 141,369 $ 16 198,278 (57,052) 127
Beginning Balance, shares at Dec. 31, 2021   16,168,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (36,313)        
Other comprehensive income (loss), net of tax (2,131)        
Ending Balance at Sep. 30, 2022 109,329 $ 17 204,681 (93,365) (2,004)
Ending Balance, shares at Sep. 30, 2022   16,556      
Beginning Balance at Mar. 31, 2022 136,362 $ 16 200,176 (63,528) (302)
Beginning Balance, shares at Mar. 31, 2022   16,245,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (17,826)     (17,826)  
Other comprehensive income (loss), net of tax (1,090)       (1,090)
Issuance of restricted stock, shares   257,000      
Stock options exercised 177 $ 1 176    
Stock options exercised, shares   24,000      
Stock-based compensation 2,030   2,030    
Ending Balance at Jun. 30, 2022 119,653 $ 17 202,382 (81,354) (1,392)
Ending Balance, shares at Jun. 30, 2022   16,526,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (12,011)     (12,011)  
Other comprehensive income (loss), net of tax (612)       (612)
Issuance of restricted stock, shares   16      
Stock options exercised 88   88    
Stock options exercised, shares   14      
Stock-based compensation 2,211   2,211    
Ending Balance at Sep. 30, 2022 109,329 $ 17 204,681 (93,365) (2,004)
Ending Balance, shares at Sep. 30, 2022   16,556      
Beginning Balance at Dec. 31, 2022 88,941 $ 17 206,916 (116,598) (1,394)
Beginning Balance, shares at Dec. 31, 2022   16,569,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (6,705)     (6,705)  
Other comprehensive income (loss), net of tax 445       445
Issuance of restricted stock, shares   14,000      
Stock options exercised 124   124    
Stock options exercised, shares   21,000      
Stock-based compensation 1,959   1,959    
Ending Balance at Mar. 31, 2023 84,764 $ 17 208,999 (123,303) (949)
Ending Balance, shares at Mar. 31, 2023   16,604,000      
Beginning Balance at Dec. 31, 2022 88,941 $ 17 206,916 (116,598) (1,394)
Beginning Balance, shares at Dec. 31, 2022   16,569,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (26,231)        
Other comprehensive income (loss), net of tax $ 394        
Stock options exercised, shares 419,233        
Ending Balance at Sep. 30, 2023 $ 72,402 $ 17 216,214 (142,829) (1,000)
Ending Balance, shares at Sep. 30, 2023   17,409      
Beginning Balance at Mar. 31, 2023 84,764 $ 17 208,999 (123,303) (949)
Beginning Balance, shares at Mar. 31, 2023   16,604,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (15,920)     (15,920)  
Other comprehensive income (loss), net of tax (35)       (35)
Issuance of restricted stock, shares   469,000      
Stock options exercised 1,234   1,234    
Stock options exercised, shares   322,000      
Stock-based compensation 4,986   4,986    
Repurchase of common stock (974)   (974)    
Repurchase of common stock, shares   (86,000)      
Ending Balance at Jun. 30, 2023 74,055 $ 17 214,245 (139,223) (984)
Ending Balance, shares at Jun. 30, 2023   17,309,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (3,606)     (3,606)  
Other comprehensive income (loss), net of tax (16)       (16)
Issuance of restricted stock, shares   24      
Stock options exercised 360   360    
Stock options exercised, shares   76      
Stock-based compensation 1,609   1,609    
Ending Balance at Sep. 30, 2023 $ 72,402 $ 17 $ 216,214 $ (142,829) $ (1,000)
Ending Balance, shares at Sep. 30, 2023   17,409